{"id":"https://openalex.org/W3013328059","doi":"https://doi.org/10.3389/fphar.2020.00333","title":"Both Pharmacokinetic Variability and Granuloma Heterogeneity Impact the Ability of the First-Line Antibiotics to Sterilize Tuberculosis Granulomas","display_name":"Both Pharmacokinetic Variability and Granuloma Heterogeneity Impact the Ability of the First-Line Antibiotics to Sterilize Tuberculosis Granulomas","alternate_titles":[],"publication_year":2020,"publication_date":"2020-03-24","ids":{"openalex":"https://openalex.org/W3013328059","doi":"https://doi.org/10.3389/fphar.2020.00333","mag":"3013328059","pmid":"https://pubmed.ncbi.nlm.nih.gov/32265707","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7105635"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2020.00333","doi":"https://doi.org/10.3389/fphar.2020.00333","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.00333","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00333/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3013328059"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00333/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008993691","display_name":"Joseph M. Cicchese","orcid":"https://orcid.org/0000-0003-2128-0702","observed_orcids":["https://orcid.org/0000-0003-2128-0702"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph M. Cicchese","raw_affiliation_strings":["Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007366821","display_name":"Veronique Anne Dartois","orcid":"https://orcid.org/0000-0001-9470-5009","observed_orcids":["https://orcid.org/0000-0001-9470-5009"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]},{"id":"https://openalex.org/I4210148589","display_name":"Hackensack Meridian Health","ror":"https://ror.org/04p5zd128","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148589"]},{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V\u00e9ronique Dartois","raw_affiliation_strings":["Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, United States","Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, United States","institution_ids":["https://openalex.org/I4210148589"]},{"raw_affiliation_string":"Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States","institution_ids":["https://openalex.org/I102322142","https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067786863","display_name":"Denise E. Kirschner","orcid":"https://orcid.org/0000-0002-1053-2591","observed_orcids":["https://orcid.org/0000-0002-1053-2591"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Denise E. Kirschner","raw_affiliation_strings":["Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066699569","display_name":"Jennifer J. Linderman","orcid":"https://orcid.org/0000-0002-1519-5088","observed_orcids":["https://orcid.org/0000-0002-1519-5088"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jennifer J. Linderman","raw_affiliation_strings":["Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5066699569","https://openalex.org/A5067786863"],"corresponding_institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.0261,"has_fulltext":true,"cited_by_count":50,"citation_normalized_percentile":{"value":0.88314905,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":null,"first_page":"333","last_page":"333"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10482","display_name":"Mathematical and Theoretical Epidemiology and Ecology Models","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2604","display_name":"Applied Mathematics"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.9490000009536743},{"id":"https://openalex.org/keywords/first-line-antibiotics","display_name":"first-line antibiotics","score":0.9409999847412109},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9950000047683716},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":1.0},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pyrazinamide","display_name":"pyrazinamide","score":1.0},{"id":"https://openalex.org/keywords/multiscale-computational-model","display_name":"multiscale computational model","score":0.7360000014305115},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.6759999990463257},{"id":"https://openalex.org/keywords/bacterial-subpopulations","display_name":"bacterial subpopulations","score":0.6290000081062317},{"id":"https://openalex.org/keywords/drug-susceptible-tuberculosis","display_name":"drug-susceptible tuberculosis","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.8176937699317932},{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.763660192489624},{"id":"https://openalex.org/C2780459521","wikidata":"https://www.wikidata.org/wiki/Q417571","display_name":"Pyrazinamide","level":4,"score":0.7245674133300781},{"id":"https://openalex.org/C2780140890","wikidata":"https://www.wikidata.org/wiki/Q1129338","display_name":"Granuloma","level":2,"score":0.6800373196601868},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.6728804111480713},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6476171612739563},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.46126964688301086},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.44093117117881775},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.42883455753326416},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.402546226978302},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32662665843963623},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2974705696105957},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.27684956789016724},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18681490421295166},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.1866762638092041}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2020.00333","doi":"https://doi.org/10.3389/fphar.2020.00333","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.00333","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00333/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6075582","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7105635","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7105635","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7105635/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:32265707","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32265707","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:acbad03bd7b94fb2af3327865b37c85f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/acbad03bd7b94fb2af3327865b37c85f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 11 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2020.00333","doi":"https://doi.org/10.3389/fphar.2020.00333","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.00333","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00333/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4053009245","display_name":null,"funder_award_id":"MCB140228","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"},{"id":"https://openalex.org/G4361046158","display_name":"A MALDI LTQ Orbitrap XL Mass Spectrometer for BioImaging","funder_award_id":"S10OD018072","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5044230080","display_name":"A Multi-scale systems pharmacology approach to TB therapy","funder_award_id":"U01HL131072","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6253692092","display_name":"Target based discovery of next generation pyrazinamide","funder_award_id":"R01AI106398","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6279167003","display_name":"Lesion-centric optimization of multidrug therapies for tuberculosis","funder_award_id":"R01AI150684","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6531392673","display_name":"A QTRAP 6500 LC-MS/MS System from SCIEX for high accuracy drug content analysis","funder_award_id":"S10OD023524","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6541289098","display_name":"Predicting protective T-cell responses in Tuberculosis using a systems biology approach","funder_award_id":"R01AI123093","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6778350887","display_name":"XSEDE: eXtreme Science and Engineering Discovery Environment","funder_award_id":"1053575","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332359","display_name":"Office of Science","ror":"https://ror.org/00mmn6b08"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3013328059.pdf","grobid_xml":"https://content.openalex.org/works/W3013328059.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W1414898727","https://openalex.org/W1777095277","https://openalex.org/W1834506558","https://openalex.org/W1993316345","https://openalex.org/W1999086719","https://openalex.org/W2000710967","https://openalex.org/W2003081219","https://openalex.org/W2006433225","https://openalex.org/W2011386209","https://openalex.org/W2035685562","https://openalex.org/W2036084890","https://openalex.org/W2040047967","https://openalex.org/W2045673103","https://openalex.org/W2055786949","https://openalex.org/W2060626299","https://openalex.org/W2062698739","https://openalex.org/W2070361087","https://openalex.org/W2072475014","https://openalex.org/W2075271267","https://openalex.org/W2092824142","https://openalex.org/W2097465589","https://openalex.org/W2102252052","https://openalex.org/W2109028417","https://openalex.org/W2111276287","https://openalex.org/W2120390077","https://openalex.org/W2120761149","https://openalex.org/W2125168028","https://openalex.org/W2133994049","https://openalex.org/W2134655561","https://openalex.org/W2135355814","https://openalex.org/W2136460896","https://openalex.org/W2141890333","https://openalex.org/W2152803686","https://openalex.org/W2155881009","https://openalex.org/W2160556418","https://openalex.org/W2173473449","https://openalex.org/W2192284249","https://openalex.org/W2193482135","https://openalex.org/W2291506885","https://openalex.org/W2296873124","https://openalex.org/W2404944565","https://openalex.org/W2469325637","https://openalex.org/W2473896701","https://openalex.org/W2516938750","https://openalex.org/W2528836208","https://openalex.org/W2530722318","https://openalex.org/W2543303947","https://openalex.org/W2606937425","https://openalex.org/W2620347821","https://openalex.org/W2731136078","https://openalex.org/W2736181852","https://openalex.org/W2750382482","https://openalex.org/W2751370007","https://openalex.org/W2764287995","https://openalex.org/W2772818769","https://openalex.org/W2793753655","https://openalex.org/W2797921335","https://openalex.org/W2799300912","https://openalex.org/W2799393161","https://openalex.org/W2883407316","https://openalex.org/W2889897651","https://openalex.org/W2905261734","https://openalex.org/W2907559772","https://openalex.org/W2913666203","https://openalex.org/W2933620934","https://openalex.org/W2987076930","https://openalex.org/W4235935369"],"related_works":["https://openalex.org/W3193728613","https://openalex.org/W2036084890","https://openalex.org/W2750382482","https://openalex.org/W6902397458","https://openalex.org/W4407701286","https://openalex.org/W2005748666","https://openalex.org/W4415303083","https://openalex.org/W2173473449","https://openalex.org/W4380853449","https://openalex.org/W4410932207"],"abstract_inverted_index":{"Tuberculosis":[0],"(TB)":[1],"remains":[2],"as":[3],"one":[4],"of":[5,14,28,131,145,166,176],"the":[6,12,126,164,183],"world's":[7],"deadliest":[8],"infectious":[9],"diseases":[10],"despite":[11],"use":[13,72],"standardized":[15],"antibiotic":[16,37,86,146,195],"therapies.":[17],"Recommended":[18],"therapy":[19,196],"for":[20,129,197],"drug-susceptible":[21],"TB":[22,130],"is":[23,52],"up":[24],"to":[25,33,42,54,65,78,92,96,149,158,168,179,193],"6":[26],"months":[27],"antibiotics.":[29],"Factors":[30],"that":[31,142],"contribute":[32],"lengthy":[34],"regimens":[35],"include":[36],"underexposure":[38],"in":[39,170,182],"lesions":[40],"due":[41,148],"poor":[43],"pharmacokinetics":[44,87],"(PK)":[45],"and":[46,64,82,88,113,138,154,172],"complex":[47,155],"granuloma":[48,80,97,114,119,160],"compositions,":[49],"but":[50],"it":[51],"difficult":[53],"quantify":[55],"how":[56,105],"individual":[57],"antibiotics":[58,167],"are":[59],"affected":[60],"by":[61],"these":[62,68],"factors":[63],"what":[66],"extent":[67],"impact":[69,118],"treatments.":[70],"We":[71,121,140],"our":[73],"next-generation":[74],"multi-scale":[75],"computational":[76],"model":[77],"simulate":[79],"formation":[81],"function":[83],"together":[84],"with":[85,125],"pharmacodynamics,":[89],"allowing":[90],"us":[91],"predict":[93],"conditions":[94],"leading":[95],"sterilization.":[98,120],"In":[99],"this":[100],"work,":[101],"we":[102],"focus":[103,122],"on":[104,123],"PK":[106,111,152],"variability,":[107],"determined":[108],"from":[109],"human":[110],"data,":[112],"heterogeneity":[115],"each":[116],"quantitatively":[117],"treatment":[124],"standard":[127],"regimen":[128],"four":[132],"first-line":[133],"antibiotics:":[134],"isoniazid,":[135],"rifampin,":[136],"ethambutol,":[137],"pyrazinamide.":[139],"find":[141],"low":[143],"levels":[144],"concentration":[147],"naturally":[150],"occurring":[151],"variability":[153],"granulomas":[156,171],"leads":[157],"longer":[159],"sterilization":[161],"times.":[162],"Additionally,":[163],"ability":[165],"distribute":[169],"kill":[173],"different":[174],"subpopulations":[175],"bacteria":[177],"contributes":[178],"their":[180],"specialization":[181],"more":[184],"efficacious":[185],"combination":[186],"therapy.":[187],"These":[188],"results":[189],"can":[190],"inform":[191],"strategies":[192],"improve":[194],"TB.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3013328059","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-04-03T00:00:00"}
